4//SEC Filing
Ford Robert B 4
Accession 0001415889-24-023389
CIK 0000001800other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 5:24 PM ET
Size
15.5 KB
Accession
0001415889-24-023389
Insider Transaction Report
Form 4
Ford Robert B
DirectorCHAIRMAN AND CEO
Transactions
- Exercise/Conversion
Common shares without par value
2024-09-12$47.00/sh+127,436$5,989,492→ 347,495 total - Exercise/Conversion
Common shares without par value
2024-09-12$48.90/sh+14,243$696,483→ 361,738 total - Sale
Common shares without par value
2024-09-12$116.04/sh−80,299$9,317,896→ 281,439 total - Sale
Common shares without par value
2024-09-12$116.90/sh−61,380$7,175,322→ 220,059 total - Exercise/Conversion
Option (right to buy)
2024-09-12−127,436→ 0 totalExercise: $47.00From: 2018-02-20Exp: 2025-02-19→ Common Shares (127,436 underlying) - Exercise/Conversion
Option (right to buy)
2024-09-12−14,243→ 0 totalExercise: $48.90From: 2018-06-01Exp: 2025-05-31→ Common Shares (14,243 underlying)
Holdings
- 197,403(indirect: By Trust)
Common shares without par value
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.58 to $116.54, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.58 to $117.29, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Held in the Ford Family Trust DTD June 2, 2014. The reporting person is co-trustee of the trust.
- [F4]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001612571
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 5:24 PM ET
- Size
- 15.5 KB